BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 34362498)

  • 1. [Clinical Characteristics and Prognostic Factors of Primary FL Patients with Grade 3 or Large B Cell Transformation].
    Li ZM; Zhang YP; Xing PT; Zhan XR
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Aug; 29(4):1169-1174. PubMed ID: 34362498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical Significance of Detecting CD4
    Liu W; Zhagn GX; Shi WZ; Dong L; Liu H; Shen XL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):449-454. PubMed ID: 28446291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical characteristics and survival analysis of
    Ying ZT; Feng HY; Mi L; Song YQ; Wang XP; Zheng W; Lin NJ; Tu MF; Xie Y; Ping LY; Zhang C; Liu WP; Deng LJ; Zhu J
    Zhonghua Xue Ye Xue Za Zhi; 2018 Sep; 39(9):745-750. PubMed ID: 30369186
    [No Abstract]   [Full Text] [Related]  

  • 4. Prognostic value of the Follicular Lymphoma International Prognostic Index score in marginal zone lymphoma: an analysis of clinical presentation and outcome in 144 patients.
    Heilgeist A; McClanahan F; Ho AD; Witzens-Harig M
    Cancer; 2013 Jan; 119(1):99-106. PubMed ID: 22736411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Follicular Lymphoma Evaluation Index (FLEX): A new clinical prognostic model that is superior to existing risk scores for predicting progression-free survival and early treatment failure after frontline immunochemotherapy.
    Mir F; Mattiello F; Grigg A; Herold M; Hiddemann W; Marcus R; Seymour JF; Bolen CR; Knapp A; Nielsen T; Casulo C
    Am J Hematol; 2020 Dec; 95(12):1503-1510. PubMed ID: 32815559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Follicular lymphoma in early stages: high risk of relapse and usefulness of the Follicular Lymphoma International Prognostic Index to predict the outcome of patients.
    Plancarte F; López-Guillermo A; Arenillas L; Montoto S; Giné E; Muntañola A; Ferrer A; Villamor N; Bosch F; Colomo L; Balaguer O; Campo E; Montserrat E
    Eur J Haematol; 2006 Jan; 76(1):58-63. PubMed ID: 16343272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Follicular lymphoma patients with a high FLIPI score and a high tumor burden: a risk stratification model.
    Andjelić B; Todorović-Balint M; Antić D; Bila J; Djurašinović V; Mihaljević B
    Vojnosanit Pregl; 2015 Jan; 72(1):26-32. PubMed ID: 26043587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Follicular Lymphoma International Prognostic Index (FLIPI) and the histological subtype are the most important factors to predict histological transformation in follicular lymphoma.
    Giné E; Montoto S; Bosch F; Arenillas L; Mercadal S; Villamor N; Martínez A; Colomo L; Campo E; Montserrat E; López-Guillermo A
    Ann Oncol; 2006 Oct; 17(10):1539-45. PubMed ID: 16940035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical Features, Treatment and Prognostic Factors of 94 Patients with Follicular Lymphoma].
    DU XY; Hu K; Zhao W; Yang P; Wan W; Jing HM; Ke XY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Jun; 26(3):756-764. PubMed ID: 29950216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of the FLIPI score for follicular lymphoma with period of diagnosis and type of treatment.
    Arcaini L; Colombo N; Passamonti F; Burcheri S; Orlandi E; Brusamolino E; Della Porta M; Rumi E; Montanari F; Pascutto C; Paulli M; Lazzarino M
    Leuk Res; 2006 Mar; 30(3):277-82. PubMed ID: 16112730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basal (18)F-FDG PET/CT in follicular lymphoma: A comparison of metabolic and clinical variables in the prognostic assessment.
    Jiménez Londoño GA; García Vicente AM; Poblete García VM; Amo-Salas M; Calle Primo C; Ibañez García Á; Martínez Sanchís B; López-Fidalgo JF; Solano Ramos F; Martínez Hellín A; Díaz Morfa M; Soriano Castrejón Á
    Rev Esp Med Nucl Imagen Mol; 2016; 35(5):298-305. PubMed ID: 27312693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic indexes in follicular lymphoma: a comparison of different prognostic systems.
    Perea G; Altés A; Montoto S; López-Guillermo A; Domingo-Doménech E; Fernández-Sevilla A; Ribera JM; Grau J; Pedro C; Angel Hernández J; Estany C; Briones J; Martino R; Sureda A; Sierra J; Montserrat E
    Ann Oncol; 2005 Sep; 16(9):1508-13. PubMed ID: 15939718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prognosis analysis of primary breast diffuse large B cell lymphoma].
    Zhu YH; Meng WJ; He LH; Jia YS; Tong ZS
    Zhonghua Zhong Liu Za Zhi; 2019 Mar; 41(3):235-240. PubMed ID: 30917462
    [No Abstract]   [Full Text] [Related]  

  • 14. Utility of the Follicular Lymphoma International Prognostic Index and the International Prognostic Index in assessing prognosis and predicting first-line treatment efficacy in follicular lymphoma patients.
    Formica V; Norman AR; Cunningham D; Wotherspoon A; Oates J; Chong G
    Acta Haematol; 2009; 122(4):193-9. PubMed ID: 19887775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mantle cell lymphoma: prognostic capacity of the Follicular Lymphoma International Prognostic Index.
    Møller MB; Pedersen NT; Christensen BE
    Br J Haematol; 2006 Apr; 133(1):43-9. PubMed ID: 16512827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the prognostic indices IPI and FLIPI in patients with mucosa-associated lymphoid tissue lymphoma.
    Troch M; Wöhrer S; Raderer M
    Anticancer Res; 2010 Feb; 30(2):635-9. PubMed ID: 20332482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic ability of five clinical risk scores in follicular lymphoma: A single-center evaluation.
    Mozas P; Rivero A; Rivas-Delgado A; Correa JG; Condom M; Nadeu F; Giné E; Delgado J; Villamor N; Campo E; Magnano L; López-Guillermo A
    Hematol Oncol; 2021 Dec; 39(5):639-649. PubMed ID: 34494300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nongastric marginal zone B-cell lymphoma: a prognostic model from a retrospective multicenter study.
    Oh SY; Kwon HC; Kim WS; Park YH; Kim K; Kim HJ; Kwon JM; Lee J; Ko YH; Ahn YC; Oh SJ; Lee SI; Bang SM; Kim JH; Park J; Ryoo BY; Lee SS; Kim HY; Park K; Kim HJ
    Cancer Lett; 2007 Dec; 258(1):90-7. PubMed ID: 17936499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry.
    Pastore A; Jurinovic V; Kridel R; Hoster E; Staiger AM; Szczepanowski M; Pott C; Kopp N; Murakami M; Horn H; Leich E; Moccia AA; Mottok A; Sunkavalli A; Van Hummelen P; Ducar M; Ennishi D; Shulha HP; Hother C; Connors JM; Sehn LH; Dreyling M; Neuberg D; Möller P; Feller AC; Hansmann ML; Stein H; Rosenwald A; Ott G; Klapper W; Unterhalt M; Hiddemann W; Gascoyne RD; Weinstock DM; Weigert O
    Lancet Oncol; 2015 Sep; 16(9):1111-1122. PubMed ID: 26256760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Follicular non-Hodgkin's lymphoma: correlation between histology, pathophysiology, cytogenetic, prognostic factors, treatment, survival.
    Găman AM
    Rom J Morphol Embryol; 2013; 54(1):71-6. PubMed ID: 23529311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.